Assenagon Asset Management S.A. Gilead Sciences, Inc. Transaction History

Assenagon Asset Management S.A.

$54.8 Billion
Q1 2025

A detailed history of Assenagon Asset Management S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 361,594 shares of GILD stock, worth $38.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

361,594

Previous 585,076 38.2%

Holding current value

$38.2 Million

Previous $54 Million 25.03%

% of portfolio

0.07%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$89.14 - $117.41 $19.9 Million - $26.2 Million	-223,482 Reduced 38.2%	361,594 $40.5 Million
Q4 2024 Jan 14, 2025	SELL	$83.95 - $97.9 $147 Million - $172 Million	-1,752,641 Reduced 74.97%	585,076 $54 Million
Q3 2024 Oct 23, 2024	BUY	$66.59 - $83.99 $95.7 Million - $121 Million	1,437,842 Added 159.78%	2,337,717 $196 Million
Q2 2024 Jul 18, 2024	SELL	$63.15 - $72.88 $38.5 Million - $44.5 Million	-610,405 Reduced 40.42%	899,875 $61.7 Million
Q1 2024 Apr 24, 2024	BUY	$71.58 - $87.29 $85.6 Million - $104 Million	1,195,507 Added 379.8%	1,510,280 $111 Million
Q4 2023 Jan 17, 2024	SELL	$73.27 - $83.09 $23.3 Million - $26.4 Million	-317,901 Reduced 50.25%	314,773 $25.5 Million
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $22.8 Million - $24.8 Million	307,785 Added 94.74%	632,674 $47.4 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $32.4 Million - $37 Million	-426,282 Reduced 56.75%	324,889 $25 Million
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $2.46 Million - $2.8 Million	-31,814 Reduced 4.06%	751,171 $62.3 Million
Q4 2022 Jan 12, 2023	SELL	$62.32 - $89.47 $55.9 Million - $80.3 Million	-897,675 Reduced 53.41%	782,985 $67.2 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $75.2 Million - $85.8 Million	1,262,303 Added 301.73%	1,680,660 $104 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $24.7 Million - $27.8 Million	-427,715 Reduced 50.55%	418,357 $25.9 Million
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $13.7 Million - $17.2 Million	-237,202 Reduced 21.9%	846,072 $50.3 Million
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $9.73 Million - $11 Million	150,027 Added 16.08%	1,083,274 $78.7 Million
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $61.2 Million - $66 Million	903,494 Added 3036.65%	933,247 $65.2 Million
Q2 2021 Jul 15, 2021	SELL	$63.47 - $69.35 $14.4 Million - $15.8 Million	-227,280 Reduced 88.42%	29,753 $2.05 Million
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $33.7 Million - $38.5 Million	-561,768 Reduced 68.61%	257,033 $16.6 Million
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $45.3 Million - $51.6 Million	799,738 Added 4195.24%	818,801 $47.7 Million
Q3 2020 Oct 07, 2020	SELL	$62.1 - $78.08 $1.23 Million - $1.54 Million	-19,766 Reduced 50.91%	19,063 $1.21 Million
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $21.5 Million - $25 Million	-297,721 Reduced 88.46%	38,829 $2.99 Million
Q1 2020 Apr 17, 2020	SELL	$62.63 - $80.22 $54.2 Million - $69.4 Million	-865,124 Reduced 71.99%	336,550 $25.2 Million
Q4 2019 Jan 17, 2020	BUY	$61.62 - $67.78 $34.6 Million - $38 Million	560,774 Added 87.5%	1,201,674 $78.1 Million
Q3 2019 Oct 16, 2019	SELL	$62.51 - $69.0 $12.6 Million - $13.9 Million	-201,096 Reduced 23.88%	640,900 $40.6 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $41.4 Million - $46.4 Million	669,035 Added 386.81%	841,996 $56.9 Million
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $37.6 Million - $42.1 Million	-601,098 Reduced 77.66%	172,961 $11.2 Million
Q4 2018 Jan 23, 2019	BUY	$60.54 - $79.0 $38.4 Million - $50.1 Million	633,699 Added 451.48%	774,059 $48.4 Million
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $26.1 Million - $28.9 Million	-365,689 Reduced 72.26%	140,360 $10.8 Million
Q2 2018 Jul 17, 2018	BUY	$64.88 - $75.68 $19.3 Million - $22.5 Million	297,098 Added 142.19%	506,049 $35.8 Million
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $13.7 Million - $16.7 Million	188,050 Added 899.72%	208,951 $15.8 Million
Q4 2017 Jan 25, 2018	SELL	$71.15 - $83.52 $61.2 Million - $71.8 Million	-859,463 Reduced 97.63%	20,901 $1.5 Million
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $63.5 Million - $75.2 Million	880,364	880,364 $71.3 Million

Others Institutions Holding GILD

# of Institutions

2,139

Shares Held

987M

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $132B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Gilead Sciences, Inc. Transaction History